Patents by Inventor Raymond L. Benza

Raymond L. Benza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10481151
    Abstract: The present disclosure provides methods of obtaining, recovering and culturing pulmonary arterial endothelial cells from an individual patient subjected to a right heart catheterization in regard to diagnosis of pulmonary hypertension. These isolated pulmonary arterial endothelial cells from an individual patient may be utilized to generate cellular phenotyping profile for the cell population, allowing generation of a personalized pharmacotherapy regime to assist the clinician in treatment and prognosis of the disorder for an individual patient.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: November 19, 2019
    Assignee: Allegheny-Singer Research Institute
    Inventors: Michael J. Passineau, Srinivas Murali, Raymond L. Benza, Jonathan B. Pollett
  • Publication number: 20180067104
    Abstract: The present disclosure provides methods of obtaining, recovering and culturing pulmonary arterial endothelial cells from an individual patient subjected to a right heart catheterization in regard to diagnosis of pulmonary hypertension. These isolated pulmonary arterial endothelial cells from an individual patient may be utilized to generate cellular phenotyping profile for the cell population, allowing generation of a personalized pharmacotherapy regime to assist the clinician in treatment and prognosis of the disorder for an individual patient.
    Type: Application
    Filed: November 8, 2017
    Publication date: March 8, 2018
    Inventors: Michael J. Passineau, Srinivas Murali, Raymond L. Benza, Jonathan B. Pollett
  • Patent number: 9835617
    Abstract: The present disclosure provides methods of obtaining, recovering and culturing pulmonary arterial endothelial cells from an individual patient, subjected to a right heart catheterization in regard to diagnosis of pulmonary hypertension. These isolated pulmonary arterial endothelial cells from an individual patient may be utilized to generate cellular phenotyping profile for the cell population, allowing generation of a personalized pharmacotherapy regime to assist the clinician in treatment and prognosis of the disorder for an individual patient.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: December 5, 2017
    Assignee: Allegheny-Singer Research Institute
    Inventors: Michael J. Passineau, Srinivas Murali, Raymond L. Benza, Jonathan B. Pollett
  • Publication number: 20170007188
    Abstract: A method of and system for determining ventricular ejection fraction of a patient is provided. A pressure sensing device captures pulmonary arterial pressure data for a patient over time. A processing device receives the pressure data, generates a first time-resolved pressure curve, displaces the pressure values of the first time-resolved curve at least one time point and subtracts the displaced pressure values from the received pressure data to form a second time-resolved pressure curve so that the second curve has two or more distinct pulses from which an initial pulse may be isolated and an area may be calculated. The processing device determines an average pressure by averaging the pressure data of the first curve over a cardiac cycle of data; determines a cardiac chamber stroke volume for the patient; and uses the determined cardiac chamber stroke volume and determined average pressure to determine an ejection fraction for the patient.
    Type: Application
    Filed: July 11, 2016
    Publication date: January 12, 2017
    Inventors: Robert W. Biederman, Raymond L. Benza, Mark Doyle
  • Publication number: 20150219631
    Abstract: The present disclosure provides methods of obtaining, recovering and culturing pulmonary arterial endothelial cells from an individual patient, subjected to a right heart catheterization in regard to diagnosis of pulmonary hypertension. These isolated pulmonary arterial endothelial cells from an individual patient may be utilized to generate cellular phenotyping profile for the cell population, allowing generation of a personalized pharmacotherapy regime to assist the clinician in treatment and prognosis of the disorder for an individual patient.
    Type: Application
    Filed: September 10, 2013
    Publication date: August 6, 2015
    Inventors: Michael J. Passineau, Srinivas Murali, Raymond L. Benza, Jonathan B. Pollett
  • Publication number: 20020146424
    Abstract: This invention to provides means of achieving cardiovascular protective effects by administration of fibrinolytic activity increasing amounts of catechin, epicatechin, quercetin and/or resveratrol or their complexes individually or in combination without administration of ethanol.
    Type: Application
    Filed: February 20, 2002
    Publication date: October 10, 2002
    Inventors: Raymond L. Benza, Francois M. Booyse, Michael L. Aikens